Guide for cost-benefit analysis for investments in laboratory biosafety and biosecurity in animal health systems

Cost-benefit analysis (CBA) has historically been the economic tool of choice for appraising public investments in animal health (Rushton, 2009). Costs and benefits are compared, typically over a long period of time, and an analysis is created using discounting to reflect their value over time, taking opportunity costs into account. CBAs are limited by their heavy reliance on data and assumptions, yet the results from such an analysis can provide a strong motivator to effect change.

This document outlines an approach for appraising investments in animal health laboratories by considering both the direct and indirect benefits that may come from improved biosafety and biosecurity.